Registry for AtriCure Devices in Inappropriate Sinus Tachycardia and POTS

This registry is collecting information on how well AtriCure commercially available devices work and how safe they are when used to treat Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). IST and POTS are conditions that can cause a fast heartbeat. The study is looking at people who are already scheduled to have, or have had, a procedure using AtriCure devices to treat their IST or POTS. The main goal is to see how these devices perform over 12 months. This is an observational study, meaning researchers will collect data from real-world use. The current status of the study is unclear, but it aims to include about 500 participants.

Study design
This is an observational study, meaning researchers will collect information from people already undergoing treatment, rather than assigning treatments. It aims to include about 500 participants.
What's involved
You would need to be willing to provide written informed consent to participate in this registry.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at 12 months, suggesting participants will be followed for at least this duration after their procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05107635

Inappropriate Sinus Tachycardia Registry

Recruiting
Not specifiedAges 18+Observational
AtriCure, Inc.
~500 participants
Updated 2026-08-27 on ClinicalTrials.gov
What's tested:AtriCure Commercially Available Devices

At a glance

Recruiting sites
15 of 15 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
AtriCure commercially available devices used to treat IST or POTS
Measured over 5 years
Inappropriate Sinus Tachycardia
Postural Tachycardia Syndrome

NCT05107635

Where you'd take part

This study runs at 15 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Central Clinic Hospital

    Warsaw, Polandstudy coordinator listed

    Recruiting

  • HCA Osceola Regional Medical Center

    Kissimmee, Floridastudy coordinator listed

    Recruiting

  • Intermountain Medical Center

    Murray, Utahstudy coordinator listed

    Recruiting

  • IRCCS Ospedale San Raffaele

    San Raffaele, Italystudy coordinator listed

    Recruiting

  • Kansas City Cardiac Arrhythmia Research

    Kansas City, Kansasstudy coordinator listed

    Recruiting

  • Loma Linda University Health

    Loma Linda, Californiastudy coordinator listed

    Recruiting

  • MedStar Health Research Institute

    Hyattsville, Marylandstudy coordinator listed

    Recruiting

  • Sarasota Memorial Hospital

    Sarasota, Floridastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Opens a ready-to-send draft in your own email app — review before sending.

  • AtriCure commercially available devices used to treat IST or POTS5 years

    The IST Registry will attempt to enroll all eligible patients at registry sites who have already had or are scheduled to have a procedure to treat IST/POTS that includes the use of at least one commercially available AtriCure cardiac ablation devices.